Xiaohan Lou

510 total citations
21 papers, 386 citations indexed

About

Xiaohan Lou is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaohan Lou has authored 21 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Xiaohan Lou's work include Cancer, Hypoxia, and Metabolism (5 papers), Immune cells in cancer (5 papers) and Immunotherapy and Immune Responses (4 papers). Xiaohan Lou is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Immune cells in cancer (5 papers) and Immunotherapy and Immune Responses (4 papers). Xiaohan Lou collaborates with scholars based in China, Germany and Singapore. Xiaohan Lou's co-authors include Zhihai Qin, Xiaohan Yao, Ni Chen, Jiajia Wan, Zhuoyu Gu, Xiaomeng Liu, Yongjuan Li, Linyu Zhu, Ming Wang and Ozioma Udochukwu Akakuru and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaohan Lou

21 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohan Lou China 11 186 92 80 75 69 21 386
Aimin Huang China 10 129 0.7× 82 0.9× 53 0.7× 61 0.8× 33 0.5× 15 380
Dongjian Zhang China 14 187 1.0× 86 0.9× 37 0.5× 55 0.7× 26 0.4× 53 518
Liuyi Lu China 8 143 0.8× 42 0.5× 38 0.5× 53 0.7× 86 1.2× 16 376
Zilu Zhang China 10 161 0.9× 36 0.4× 50 0.6× 46 0.6× 67 1.0× 47 402
Chunxia Huang China 15 231 1.2× 44 0.5× 71 0.9× 178 2.4× 48 0.7× 40 538
Zide Chen China 13 191 1.0× 75 0.8× 50 0.6× 36 0.5× 90 1.3× 20 382
Xinyi Luo China 12 262 1.4× 94 1.0× 59 0.7× 63 0.8× 78 1.1× 30 507
Zhenfei Bi China 12 225 1.2× 49 0.5× 111 1.4× 56 0.7× 50 0.7× 20 509
Maryam Matbou Riahi Iran 9 215 1.2× 59 0.6× 54 0.7× 39 0.5× 90 1.3× 19 423
Juan Qin China 18 330 1.8× 49 0.5× 41 0.5× 104 1.4× 71 1.0× 41 734

Countries citing papers authored by Xiaohan Lou

Since Specialization
Citations

This map shows the geographic impact of Xiaohan Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Lou more than expected).

Fields of papers citing papers by Xiaohan Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohan Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Lou. The network helps show where Xiaohan Lou may publish in the future.

Co-authorship network of co-authors of Xiaohan Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohan Lou. A scholar is included among the top collaborators of Xiaohan Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohan Lou. Xiaohan Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fazhan, Xiaohan Lou, Fang Wu, et al.. (2025). A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental Asthma. Advanced Science. 12(13). e2412543–e2412543. 9 indexed citations
2.
Li, Yongjuan, Yayun Wang, Xiaohan Lou, et al.. (2024). A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy. Journal of Controlled Release. 373. 447–462. 14 indexed citations
3.
Hu, Yu, Xiaohan Lou, Kaili Zhang, et al.. (2024). Tumor necrosis factor receptor 2 promotes endothelial cell-mediated suppression of CD8+ T cells through tuning glycolysis in chemoresistance of breast cancer. Journal of Translational Medicine. 22(1). 672–672. 5 indexed citations
4.
Wang, Ming, Zhenzhen Pan, Xiaohan Yao, et al.. (2024). Chemotherapy-induced PTEN-L secretion promotes the selection of PTEN-deficient tumor cells. Journal of Experimental & Clinical Cancer Research. 43(1). 140–140. 2 indexed citations
5.
Wang, Ming, Yijie Han, Xiaohan Yao, et al.. (2024). Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid‐derived suppressor cells by instigating apolarity during ageing. SHILAP Revista de lepidopterología. 5(6). e605–e605. 1 indexed citations
6.
Chen, Ni, Kaili Zhang, Yuanyuan Yang, et al.. (2024). Chelating drug-induced labile Zn2+ with nanoparticle-encapsulated TPEN at low dose enhances lung cancer chemotherapy through inhibiting ABCB1. iScience. 27(11). 111072–111072. 1 indexed citations
7.
Wang, Ruirui, Ni Chen, Xiaohan Lou, et al.. (2023). IFNγ blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins. International Journal of Biological Sciences. 19(5). 1490–1508. 4 indexed citations
8.
Zhang, Lijing, Xiaohan Lou, Yangyang Liu, et al.. (2023). Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses. Journal of Controlled Release. 357. 133–148. 53 indexed citations
9.
Zhang, Meng, Meiling Tian, Lijing Zhang, et al.. (2023). Natural long-chain saturated fatty acids doped LNPs enabling spleen selective mRNA translation and potent cancer immunotherapy. Nano Research. 17(3). 1804–1817. 10 indexed citations
10.
Chen, Ni, Jiajia Wan, Xixi Duan, et al.. (2023). Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release. Oncogenesis. 12(1). 18–18. 11 indexed citations
11.
Cao, Hong, Ni Chen, Ruoqi Wang, et al.. (2022). Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells. Cancer Research. 82(13). 2472–2484. 7 indexed citations
12.
Chen, Ni, Xiaohan Lou, Xiaohan Yao, et al.. (2022). ZIP1+ fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn2+ transfer. Nature Communications. 13(1). 5919–5919. 22 indexed citations
13.
Zhang, Yana, Zhuoyu Gu, Jiajia Wan, et al.. (2022). Stearoyl-CoA Desaturase-1 dependent lipid droplets accumulation in cancer-associated fibroblasts facilitates the progression of lung cancer. International Journal of Biological Sciences. 18(16). 6114–6128. 31 indexed citations
14.
Zhang, Li, Linyu Zhu, Xiaohan Yao, et al.. (2022). Paclitaxel treatment enhances lymphatic metastasis of B16F10 melanoma cells via CCL21/CCR7 axis. International Journal of Biological Sciences. 18(4). 1476–1490. 13 indexed citations
15.
16.
17.
Liu, Xiaomeng, Linyu Zhu, Ruirui Wang, et al.. (2019). IFNγ inhibits fibroblast-leading tumor cell invasion through downregulating N-cadherin. Biochemical and Biophysical Research Communications. 512(3). 544–551. 7 indexed citations
18.
Wang, Ruirui, Xiaohan Lou, Guang Feng, et al.. (2019). IL-17A-stimulated endothelial fatty acid β-oxidation promotes tumor angiogenesis. Life Sciences. 229. 46–56. 27 indexed citations
19.
Lou, Xiaohan, et al.. (2019). Aspirin, a potential GLUT1 inhibitor in a vascular endothelial cell line. Open Medicine. 14(1). 552–560. 9 indexed citations
20.
Chen, Ni, Pan Ma, Ruirui Wang, et al.. (2018). Doxorubicin‐induced cardiotoxicity involves IFNγ‐mediated metabolic reprogramming in cardiomyocytes. The Journal of Pathology. 247(3). 320–332. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aimin Huang Breakdown of academic impact, for papers by Dongjian Zhang Breakdown of academic impact, for papers by Liuyi Lu Breakdown of academic impact, for papers by Zilu Zhang Breakdown of academic impact, for papers by Chunxia Huang Breakdown of academic impact, for papers by Zide Chen Breakdown of academic impact, for papers by Xinyi Luo Breakdown of academic impact, for papers by Zhenfei Bi Breakdown of academic impact, for papers by Maryam Matbou Riahi Breakdown of academic impact, for papers by Juan Qin
Rankless by CCL
2026